TRIFIRO', Gianluca
 Distribuzione geografica
Continente #
NA - Nord America 7.100
EU - Europa 4.391
AS - Asia 4.329
SA - Sud America 1.898
AF - Africa 118
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 17.853
Nazione #
US - Stati Uniti d'America 6.962
SG - Singapore 1.717
BR - Brasile 1.706
IE - Irlanda 1.271
CN - Cina 1.182
SE - Svezia 1.052
HK - Hong Kong 629
IT - Italia 424
VN - Vietnam 361
DE - Germania 322
PL - Polonia 281
UA - Ucraina 220
FI - Finlandia 206
RU - Federazione Russa 200
GB - Regno Unito 125
IN - India 96
FR - Francia 68
AR - Argentina 67
CA - Canada 63
TR - Turchia 44
MX - Messico 42
EC - Ecuador 40
NL - Olanda 40
BD - Bangladesh 38
BE - Belgio 37
ZA - Sudafrica 37
IQ - Iraq 36
ID - Indonesia 35
RO - Romania 30
UZ - Uzbekistan 29
MA - Marocco 27
VE - Venezuela 24
JP - Giappone 23
PK - Pakistan 23
AT - Austria 19
PY - Paraguay 17
LT - Lituania 14
AZ - Azerbaigian 12
CO - Colombia 12
ES - Italia 12
KE - Kenya 12
AE - Emirati Arabi Uniti 11
CL - Cile 10
EG - Egitto 10
TN - Tunisia 10
AL - Albania 9
DZ - Algeria 9
JO - Giordania 9
PA - Panama 9
PE - Perù 9
CH - Svizzera 8
IR - Iran 8
NP - Nepal 8
AU - Australia 7
BO - Bolivia 7
KZ - Kazakistan 7
OM - Oman 7
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
BY - Bielorussia 5
CR - Costa Rica 5
NI - Nicaragua 5
RS - Serbia 5
UY - Uruguay 5
BN - Brunei Darussalam 4
CI - Costa d'Avorio 4
EE - Estonia 4
GR - Grecia 4
IL - Israele 4
JM - Giamaica 4
KR - Corea 4
LK - Sri Lanka 4
LV - Lettonia 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
BG - Bulgaria 3
CY - Cipro 3
EU - Europa 3
GA - Gabon 3
GE - Georgia 3
KG - Kirghizistan 3
LB - Libano 3
MY - Malesia 3
PT - Portogallo 3
SI - Slovenia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AF - Afghanistan, Repubblica islamica di 2
AM - Armenia 2
GT - Guatemala 2
HU - Ungheria 2
KH - Cambogia 2
KW - Kuwait 2
MD - Moldavia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
QA - Qatar 2
SV - El Salvador 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 17.834
Città #
Dublin 1.270
Chandler 999
Dallas 884
Ashburn 798
Singapore 791
Hong Kong 629
Beijing 512
Jacksonville 510
Nyköping 491
Warsaw 270
Princeton 242
Los Angeles 197
Medford 187
Cambridge 180
Messina 180
The Dalles 173
Dearborn 161
Des Moines 150
Dong Ket 135
Ann Arbor 133
São Paulo 119
New York 103
Boardman 102
Munich 88
Ho Chi Minh City 87
Buffalo 85
Redondo Beach 85
Wilmington 70
Tianjin 59
Shenyang 57
Moscow 55
Rio de Janeiro 54
Jinan 51
Bremen 49
Hanoi 49
Belo Horizonte 42
San Mateo 39
Brussels 37
Nanjing 34
Rome 31
Hyderabad 30
Seattle 30
Woodbridge 30
Brasília 29
Focsani 29
Houston 29
Tashkent 29
Santa Clara 27
Curitiba 25
Frankfurt am Main 25
Guangzhou 25
Brooklyn 22
Helsinki 22
Montreal 22
Pune 22
Tokyo 22
Campinas 21
Haikou 20
Johannesburg 20
Chennai 19
Falls Church 19
Hebei 19
Denver 18
Porto Alegre 18
Chicago 17
Council Bluffs 17
Jakarta 17
Turku 17
London 16
Milan 16
Ningbo 16
Phoenix 16
Salvador 16
Taizhou 16
Baghdad 15
Catania 15
Hangzhou 15
Lanzhou 15
Stockholm 15
Haiphong 14
Juiz de Fora 14
Lancaster 14
Ottawa 14
Santo André 14
Ankara 13
Atlanta 13
Dhaka 13
Fortaleza 13
Guarulhos 13
Guayaquil 13
Nanchang 13
Nuremberg 13
Poplar 13
Zhengzhou 13
Baku 12
Boston 12
Contagem 12
Duque de Caxias 12
Quito 12
Recife 12
Totale 11.271
Nome #
1. Real World Evidence vs. Real World Data: definizioni e razionale 195
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study 162
Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study 154
Antidepressant use in the elderly: The role of pharmacodynamics and pharmacokinetics in drug safety 134
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study 131
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies 130
In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study 129
Global epidemiology of acromegaly: A systematic review and meta-analysis 128
Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach 126
About reimbursement criteria revision: effects on lipid lowering drug use in general practice of Southern Italy 125
Antipsychotic use in dementia patients in a general practice setting: A Dutch population-based study 125
Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. 124
Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: A population-based study 123
Analgesic drug use in elderly persons: A population-based study in Southern Italy 123
PATTERN PRESCRITTIVO DI FARMACI ANTIEPILETTICI NELL'ANZIANO: STUDIO DI POPOLAZIONE IN UN'AREA DEL SUD ITALIA NEGLI ANNI 2004-2007 121
Adverse drug events in emergency department population: a prospective Italian study 120
Absorbable phosphate in medication 119
Gender differences in outpatient pediatric drug utilization: A cohort study from southern Italy 118
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents? 118
Drug interactions with levothyroxine therapy in patients with hypothyroidism: observational study in general practice 115
Drug safety information through the internet: the experience of an Italian website. 114
How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010–2016 113
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations 111
“Newer and older antiepileptic drug in southern Italy: a population based study during the years 2003-2005” 110
A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. 109
12. Real World Evidence nelle valutazioni post‑marketing su farmaci generici e biosimilari 109
Treatment of Medication-Related Osteonecrosis of the Jaw and its Impact on a Patient's Quality of Life: A Single-Center, 10-Year Experience from Southern Italy 109
Acute cerebellar ataxia following meningococcal group C conjugate vaccination 107
Challenges in Post-marketing Studies of Biological Drugs in the Era of Biosimilars: A Report of the International Society for Pharmacoepidemiology 2019 Mid-Year Meeting in Rome, Italy 107
The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy 107
Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies 107
Expert opinion of nephrologists about the effectiveness of low-protein diet in different stages of chronic kidney disease (CKD) 106
CEREBELLAR STROKE IN ELDERLY PATIENT WITH BASILAR ARTERY AGENESIA: A CASE REPORT. 106
Age-related changes in pharmacodynamics: focus on drug acting on cetral nervous and cardiovascular systems 106
Burden of cardiovascular disease in elderly with Parkinson's disease who start a dopamine agonist agent 105
Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy 105
Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011 104
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 104
Monoclonal antibodies for renal diseases: current concepts and ongoing treatments 102
Antipsychotic utilization patterns among patients with schizophrenic disorder: a cross-national analysis in four countries 101
Can information on functional and cognitive status improve short-term mortality risk prediction among community-dwelling older people? A cohort study using a UK primary care database 101
Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project 100
Real world use of biological drugs in patients with psoriasis/psoriatic arthritis: a retrospective, population-based study from Southern Italy in the years 2010-2014 100
USE AND TOLERABILITY OF NEWER ANTIPSYCHOTICS AND ANTIDEPRESSANTS: A CHART REVIEW IN A PAEDIATRIC SETTING. 98
Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy 98
Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study 97
Prescribing pattern of antiepileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-2007 95
Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile? 95
Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision 94
Kidney disease in diabetic patients: From pathophysiology to pharmacological aspects with a focus on therapeutic inertia 94
Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005. 93
An overview of experimental and early investigational therapies for the treatment of polycystic kidney disease 93
Overview of the Safety of Anti-VEGF Drugs: Analysis of the Italian Spontaneous Reporting System 93
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014 93
Global epidemiology of Duchenne muscular dystrophy: An updated systematic review and meta-analysis 93
Adherence to gastroprotection during cyclooxygenase-2 inhibitor use and the risk of upper gastrointestinal events: A population-based study. 92
Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease 92
Medication is an additional source of phosphate intake in chronic kidney disease patients 92
The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study 92
“Prescribing pattern of antipsychotic drugs in Italy: a population based study in the the years 2000-2005” 91
Ckd general and clinical epidemiology 2. 91
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study 91
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in southern Italy 91
Systemic antibiotic prescribing to paediatric outpatients in 5 European countries: A population-based cohort study 90
'Use of Antipsychotics in Children and Adolescents: A Picture From the ARITMO Population-Based European Cohort Study' 90
Bisphosphonates and cardiovascular risk in elderly patients with previous cardiovascular disease: a population-based nested case-control study in Italy 90
Prescribing pattern of drugs in the treatment of osteoarthritis before and after rofecoxib withdrawal in general practice of Southern Italy 89
Biological substantiation of antipsychotic-associated pneumonia: Systematic literature review and computational analyses 89
Additional risk minimisation measures in the EU - are they eligible for assessment? 88
Profilo di tollerabilità degli antipsicotici atipici e degli inibitori selettivi della ricaptazione della serotonina in età evolutiva. 87
Interaction risk with proton pump inhibitors in general practice: Significant disagreement between different drug-related information sources 87
Tolerability of antipsychotics in children and adolescents: a prospective study. 86
A Reference Standard for Evaluation of Methods for Drug Safety Signal Detection using Electronic Healthcare Records (EHR) Databases 86
Data Extraction And Management In Networks Of Observational Health Care Databases For Scientific Research: A Comparison Among EU-ADR, OMOP, Mini-Sentinel And MATRICE Strategies 85
Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study 85
From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources 85
Point-of-Care test screening versus Case finding for paediatric coeliac disease: A pragmatic study in primary care 84
Lipid-lowering drug use in general practice of Southern Italy: Effects of reimbursement criteria revision 84
How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009–2014 84
Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during 1999-2002 years 83
Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: the effect of rofecoxib withdrawal. 82
Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection 82
The economic burden of preventable adverse drug reactions: a systematic review of observational studies 82
Oral anticoagulant therapy in Italy: prescribing prevalence and clinical reasons 81
Statins for the primary prevention of cardiovascular events in elderly patients: a picture from clinical practice without strong evidence from clinical trials. 81
A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR project. 81
Parkinsonism and severe hypothyroidism in an elderly patient: a case of lithium toxicity due to pharmacological interactions. 81
In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study 81
Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources 79
Diagnostic Yield of 2 Strategies for Adult Celiac Disease Identification in Primary Care 79
Academic output from EU-funded health research projects 78
Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas 78
Pharmacokinetics of new oral anticoagulants: implications for use in routine care 78
Adverse drug reaction-related hospitalizations in persons aged 55 years and over: a population-based study in The Netherlands 77
The Burden of Nephrotoxic Drug Prescriptions in Patients with Chronic Kidney Disease: A Retrospective Population-Based Study in Southern Italy 76
Statin treatment and mortality in community-dwelling frail older patients with diabetes mellitus: A retrospective observational study 76
Trends in paediatric macrolide use in five European countries - A population-based study 76
Long-Term Intravitreal Ranibizumab as a Potential Additional Risk Factor for Neurodegeneration in Parkinson's Disease: A Case Report. 76
Use of azithromycin and risk of ventricular arrhythmia 76
Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? 75
Totale 9.978
Categoria #
all - tutte 79.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021700 0 0 0 0 0 100 69 123 76 142 29 161
2021/20221.463 7 97 16 41 39 14 72 71 36 409 157 504
2022/20233.612 291 266 161 289 296 347 43 184 1.582 13 109 31
2023/2024871 76 154 52 84 78 173 26 54 3 49 10 112
2024/20254.331 61 59 78 241 164 113 101 1.003 1.188 262 317 744
2025/20264.471 563 828 1.018 845 1.087 130 0 0 0 0 0 0
Totale 18.425